Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.05 GBP per share
-
Shares outstanding
-
84,213,667
-
Total 13F shares
-
6,582,135
-
Share change
-
-95,797
-
Total reported value
-
$131,642,000
-
Price per share
-
$20.00
-
Number of holders
-
14
-
Value change
-
-$1,915,281
-
Number of buys
-
7
-
Number of sells
-
1
Institutional Holders of Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) as of Q1 2018
As of 31 Mar 2018 Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) had 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,582,135 shares of stock of the company.
Largest 10 holders included Vivo Capital, LLC, ORBIMED ADVISORS LLC, NEA Management Company, LLC, venBio Partners L.P., Novo Holdings A/S, Foresite Capital Management III, LLC, Tekla Capital Management LLC, Polar Capital LLP, PERCEPTIVE ADVISORS LLC, and US BANCORP \DE\.
This table shows 14 institutional shareholders of the security as of 31 Mar 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.